Latest Placement Classifieds,Free Classified Ads,Buy Sell Classified Ads Market FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices

FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices

The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post